Karim Kohansal

发表

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018

F. Azizi, D. Khalili, F. Koohi, 2022, BMC Public Health.

Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients

M. Taheri, S. Ghafouri-Fard, M. Samsami, 2021, Journal of molecular neuroscience : MN.

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

D. Khalili, F. Hadaegh, H. Baradaran, 2022, Frontiers in Endocrinology.

Determinants of the progression to type 2 diabetes and regression to normoglycemia in people with pre-diabetes: A population-based cohort study over ten years.

D. Khalili, F. Hadaegh, Ali-Siamak Habibi-Moeini, 2022, Primary care diabetes.

Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis

M. Blaha, D. Khalili, F. Hadaegh, 2022, Cardiovascular Diabetology.

Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study

M. Mansourian, F. Hadaegh, M. Daneshpour, 2023, BMC Cardiovascular Disorders.

Changes in Fasting Plasma Glucose and Risk of Mortality Events for Individuals without Diabetes over Two Decades of Follow-up: a Pooled Cohort Analysis

S.H.R. Beheshti, Karim Kohansal, K. Kohansal, 2022 .

Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?

D. Khalili, F. Hadaegh, M. Tohidi, 2023, BMC Endocrine Disorders.

Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study

F. Hadaegh, M. Tohidi, Fereidoun Azizi, 2023, Frontiers in Endocrinology.

The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models

D. Khalili, A. Ostovar, F. Hadaegh, 2023, Global heart.